Intravesical drug delivery device

Patent metadata

Field	Value
Publication number	US-9561353-B2
Application number	US-201414455463-A
Country	US
Kind code	B2
Filing date	Aug 8, 2014
Priority date	Aug 11, 2005
Publication date	Feb 7, 2017
Grant date	Feb 7, 2017

Abstract

Implant devices for intravesical administration and local drug delivery. The device has a body which includes a hollow tube formed of a biocompatible material; at least one reservoir in the tube which contains a drug; and one or more apertures through which the drug can be released. The device is configured for minimally invasive insertion into a body cavity, such as the bladder. The hollow tube may be elastomeric to permit the device to be elastically deformed from its initial shape into an elongated shape for passage through a catheter, where following such passage the device can return to or toward its initial shape to facilitate retention of the device in the body cavity. The body may have a narrow, elongated shape effective to permit insertion of the drug delivery device through a catheter without necessarily deforming the body, yet include flexible projections which effect retention within the body cavity.

First claim

We claim:

1. A drug delivery device for intravesical administration comprising:
a body which comprises a hollow tube having an outer surface, an inner surface, and a reservoir defined within the hollow tube;
a drug formulation, which comprises a drug, contained in the reservoir prior to intravesical insertion of the drug delivery device, the drug formulation being in a solid form; and
a single aperture through a sidewall of the hollow tube, the aperture providing a passageway to release the drug from the drug delivery device,
wherein the hollow tube is formed of an elastomeric material comprising a water permeable and non-resorbable polymer, and the body can be elastically deformed to permit intravesical insertion of the drug delivery device,
wherein the device is configured to permit diffusion of water in vivo through the sidewall of the hollow tube to solubilize the drug in the reservoir and then to release the solubilized drug by osmotic pressure through the single aperture.

2. The device of claim 1 , wherein no additional procedure is needed to load a pharmaceutical solution into the device after the device is released into the bladder.

3. The device of claim 1 , which can be compressed into a narrow profile to permit passage of the device through a lumen of a urethral catheter or cystoscope into a urinary bladder of a patient, and which has an expanded formation in an uncompressed state to prevent voiding of the device from the bladder.

4. The device of claim 1 , wherein the water permeable and non-resorbable polymer comprises silicone or polyurethane.

5. The device of claim 1 , wherein the drug comprises a chemotherapeutic agent and the water permeable and non-resorbable polymer comprises silicone.

Assignees

• Massachusetts Inst Technology
• Children'S Medical Center Corp

Inventors

• Lee Heejin
• Daniel Karen
• Ho Duc Hong Linh
• Cima Michael J
• Castillo Mario
• Froelich Steven
• Dimitrakov Jordan
• Kim Grace Y

Classifications

• A61L2300/63

  Crystals · CPC title

• A61L2300/45

  Mixtures of two or more drugs, e.g. synergistic mixtures · CPC title

• A61L2300/406

  Antibiotics · CPC title

• A61L29/16

  Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)} · CPC title

• A61M31/002 Primary

  Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50) · CPC title